Patent · US Expired

Anti-ribonucleotide reductase R2 subunit monoclonal antibody

US5885830A · kind A · utility

2Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 1996
Grant dateMar 23, 1999
Priority date
Expiry dateFeb 7, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/40
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

An anti-ribonucleotide reductase (RNR) R2 subunit monoclonal antibody KM1054, KM1056 or KM1060, which belongs to the IgG2a subclass, reacts with R2 subunit of RNR, and inhibits RNR activity, is disclosed. It is effective for immunologically detecting RNR and for immunologically detecting the presence of human cancer cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.